Apollo Therapeutics
Apollo Therapeutics is a collaborative joint venture between three global pharmaceutical companies (AstraZeneca, GlaxoSmithKline and Johnson & Johnson Innovation) and the technology transfer offices of Imperial College London, University College London and the University of Cambridge.
Find out more
Project Criteria
Apollo has been developed to fund a wide range of biomedical projects across a number of therapeutic areas. While the joint venture is focussed on therapeutics, or platform technologies which may aid the development and identification of therapeutics, there will be no therapeutic area bias, and any modality may be considered.
Full Project Criteria
Questions & Answers
Answers to initial questions about Apollo Therapeutics and how it will work in practice. For detailed information about any of these points, please contact you local Apollo representative.
Read more